Whalegun
Lobbying

Avadel Pharmaceuticals's latest lobbying report covers Q2 2026, at $60K. The four quarters Q4 2025–Q3 2026 total $180K. Its first report covers Q4 2022; the issues it reports most are Pharmacy and Medicare/Medicaid.

Avadel Pharmaceuticals

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$180K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Avadel Pharmaceuticals lobbying by quarter
Avadel Pharmaceuticals lobbying by quarter
QuarterAmountReports
Q4 2022$50K1
Q1 2023$50K1
Q2 2023$60K1
Q3 2023$60K1
Q4 2023$60K1
Q1 2024$60K2
Q2 2024$20K1
Q3 2024$20K1
Q4 2024$60K1
Q1 2025$60K1
Q2 2025$60K1
Q3 2025$60K1
Q4 2025$60K1
Q1 2026$60K1
Q2 2026$60K1
Q3 2026$00

By issue

  • Pharmacy$480K · 10 reports
  • Medicare and Medicaid$320K · 6 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES16 reports
  • SENATE16 reports

Firms it paid

Firm
LMH Strategic Solutions$480K10 quarters
The McManus Group$320K6 quarters

Former officials lobbying for it

Former position
ALANNA TEMMELegislative Director, U.S. Representative Jon PorterQ2 2026

Lobbying reports

Filed by
07/05for Q2LMH Strategic Solutions$60K
04/17for Q1LMH Strategic Solutions$60K
01/12for Q4 2025LMH Strategic Solutions$60K
25/10/20for Q3 2025LMH Strategic Solutions$60K
25/07/15for Q2 2025LMH Strategic Solutions$60K
25/04/18for Q1 2025LMH Strategic Solutions$60K
25/01/08for Q4 2024LMH Strategic Solutions$60K
24/10/09for Q3 2024LMH Strategic Solutions$20K
24/07/11for Q2 2024LMH Strategic Solutions$20K
24/04/22for Q1 2024The McManus Group$40K
24/04/22for Q1 2024LMH Strategic Solutions$20K
24/04/12for Q1 2024LMH Strategic SolutionsUnder $5,000
24/01/20for Q4 2023The McManus Group$60K
23/10/20for Q3 2023The McManus Group$60K
23/07/20for Q2 2023The McManus Group$60K
23/04/20for Q1 2023The McManus Group$50K
23/01/20for Q4 2022The McManus Group$50K